Covid shots designed to protect against the omicron variant trigger a weaker immune response against the rapidly emerging BQ.1.1 subvariant than the previously dominant strain, according to a new lab study.
A study yesterday in JAMA Internal Medicine shows women and racial minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.
The research was conducted by a team from the Fred Hutchinson Cancer Center, as well researchers from Beijing and London.
Vaccine hesitancy about COVID-19 vaccines is a positive predictor of negative side effects with vaccination—an example of the "nocebo" effect—according to a study today in Scientific Reports.
Nocebo, a play on placebo, is a phenomenon in which people experience negative effects on health when they have negative views or expectations surrounding medical interventions.
Paxlovid — the most widely-used medication that people can take at home to treat an active case of Covid — is now being studied as a potential treatment for those who have remained sick months or even years following infection.
Screening nearly 1 million patients, visitors, and healthcare workers at the entrance of a large hospital for COVID-19 symptoms, exposures, or travel was of limited benefit at considerable cost, finds a Yale study published yesterday in JAMA Internal Medicine.
Recent Comments